
|
LEARN MORE
IMAGE SOURCE: © Vicks Web site
|
Proctor & Gamble is voluntarily recalling three lots of its Vicks Sinex nasal spray in the United States, the United Kingdom and Germany.
During a routine quality control inspection small amounts of bacteria B. cepacia was detected. The recall affects about 120,000 bottles.
While there have been no reports of illness associated with the recalled products, the bacteria could cause serious infections for an individual with a compromised immune system or a chronic lung condition such as cystic fibrosis, P&G said in a news release. However, the bacteria pose little medical risk to healthy individuals.
The recalled medication should not be used. Consumers should contact P&G for a full refund or replacement coupon.
The nasal sprays were sold in 15 milliliters bottles in all three markets and include the following lot numbers:
In the U.S.: 9239028831 - Vicks Sinex Vapospray 12-Hour Decongestant Ultra Fine Mist
In the U.K.: 9224028832 - Vicks Sinex Micromist Aqueous Nasal Spray Solution
In Germany: 9224028833 - Wick Sinex Schnupfenspray Dosiersystem
* The lot number is listed on both the outer carton and the bottle.
Consumer Contact:
United States, call: 1.877.876.7881
United Kingdom, call: 0800.5555.15
Germany, please call: 0800.111.6131
According to a spokesman for P&G, 4.4 million bottles of the spray were sold in the U.S. alone in 2008.
The recall is just weeks after the Food and Drug Administration (FDA) warned P&G that its Vicks cold formulas with Vitamin C have false and misleading labeling. #